Company: GLPG
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001558370-25-003806
Chunk: 478

Company: GALAPAGOS NV
Filing Date: 2025-03-27
Form: 20-F
Item: Item 19
Chunk 478
---
​

F-57

31. Off-balance sheet arrangements
CONTRACTUAL OBLIGATIONS AND COMMITMENTS
On December 31, 2024, we had outstanding obligations for future purchase commitments, which become due as follows:
         ​             ​   ​       ​      ​    ​        ​        ​       ​       ​        ​     ​      ​      ​     ​       ​  
-------------------------------------------------------------------------------------------------------------------------------
​                          Total              Less than                1 - 3                    3 - 5             More than 5  
                                              1 year                   years                    years             years        
​                      ​   ​    ​                              (Euro, in thousands)             ​    ​                         
​                      ​   ​    ​         ​   ​      ​         ​       ​       ​        ​       ​    ​        ​   ​       ​    
Purchase commitments   ​   €    272,240   ​   €      189,662   ​       ​       70,323   ​       ​    10,962   ​   ​       1,293
​
​
On December 31, 2023, we had outstanding obligations for future purchase commitments, which become due as follows:
         ​             ​   ​       ​      ​    ​        ​        ​       ​        ​        ​     ​      ​      ​     ​       ​  
--------------------------------------------------------------------------------------------------------------------------------
​                          Total              Less than                1 - 3                     3 - 5             More than 5  
                                              1 year                   years                     years             years        
​                      ​   ​    ​                              (Euro, in thousands)              ​    ​                         
Purchase commitments   ​   €    408,521   ​   €      237,495   ​       €       143,532   ​       €    25,768   ​   €       1,727
​
Our purchase commitments at the end of the year 2024 included €160.9 million related to projects in development phase (2023: €239.6 million), €60.9 million for projects in discovery research phase (2023: €79.0 million), €46.0 million for shared services (2023: €45.9 million), €1.7 million for commercial and medical affairs (2023: €9.9 million), and €2.6 million related to Jyseleca® product supply chain (2023: €14.2 million).At year end 202